These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11081555)

  • 1. Randomisation in the SYMPHONY trial.
    Altman DG
    Lancet; 2000 Oct; 356(9240):1521-2. PubMed ID: 11081555
    [No Abstract]   [Full Text] [Related]  

  • 2. How hot is inflammation in acute coronary syndrome?
    Verheugt FW
    Eur Heart J; 2000 Dec; 21(24):1990-2. PubMed ID: 11102246
    [No Abstract]   [Full Text] [Related]  

  • 3. ACE inhibitor reduces cardiovascular events by 22%.
    Indian J Med Sci; 2000 Mar; 54(3):112-4. PubMed ID: 11227615
    [No Abstract]   [Full Text] [Related]  

  • 4. Sibrafiban.
    Dooley M; Goa KL
    Drugs; 1999 Feb; 57(2):225-30; discussion 231-2. PubMed ID: 10188763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from a clinical trial.
    Armstrong PW; Newby LK; Granger CB; Lee KL; Simes RJ; Van de Werf F; White HD; Califf RM;
    Circulation; 2004 Dec; 110(23):3610-4. PubMed ID: 15583090
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes.
    Lancet; 2000 Jan; 355(9201):337-45. PubMed ID: 10665552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
    Wong CK; Newby LK; Bhapker MV; Aylward PE; Pfisterer M; Alexander KP; Armstrong PW; Hochman JS; Van de Werf F; Califf RM; White HD;
    Am Heart J; 2007 Aug; 154(2):313-21. PubMed ID: 17643582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies of the effectiveness of aspirin in the prevention of major cardio-cerebrovascular occurrences].
    Mariani M; Biadi O
    Cardiologia; 1995 Dec; 40(12 Suppl 1):423-8. PubMed ID: 8998750
    [No Abstract]   [Full Text] [Related]  

  • 9. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.
    McDonagh MS; Bachmann LM; Golder S; Kleijnen J; ter Riet G
    Health Technol Assess; 2000; 4(30):1-95. PubMed ID: 11154975
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of Quyu Xiaoban capsules on clinical outcomes and platelet activation and aggregation in patients with unstable angina pectoris.
    Liu YF; Yu HM; Zhang C; Yang RX; Yan FF; Liu Y; Zhang Y; Zhao YX
    J Altern Complement Med; 2007 Jun; 13(5):571-6. PubMed ID: 17604562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Quyu xiaoban capsules on clinical outcomes and platelet activation and aggregation in patients with unstable angina pectoris.
    Liu YF; Yu HM; Zhang C; Yang RX; Yan FF; Liu Y; Zhang Y; Zhao YX
    J Altern Complement Med; 2007 Apr; 13(3):369-74. PubMed ID: 17480139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
    Kassem-Moussa H; Mahaffey KW; Graffagnino C; Tasissa G; Sila CA; Simes RJ; White HD; Califf RM; Bhapkar MV; Newby LK;
    Am Heart J; 2004 Sep; 148(3):439-46. PubMed ID: 15389230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparins in acute coronary syndrome.
    Creekmore F
    S D J Med; 2000 Jan; 53(1):21-3. PubMed ID: 10652862
    [No Abstract]   [Full Text] [Related]  

  • 14. Postmenopausal hormone use in women with acute coronary syndromes.
    Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
    J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion.
    Howard PA
    Ann Pharmacother; 2002 Nov; 36(11):1800-4. PubMed ID: 12432893
    [No Abstract]   [Full Text] [Related]  

  • 16. Unstable angina.
    Natarajan M
    Clin Evid; 2002 Jun; (7):214-26. PubMed ID: 12230645
    [No Abstract]   [Full Text] [Related]  

  • 17. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR; Yusuf S;
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks.
    De Caterina R
    Ital Heart J; 2003 Apr; 4(4):228-31. PubMed ID: 12784774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term combination therapy with aspirin and clopidogrel.
    Kumana CR; Cheung G; Lauder IJ; Cheung BM
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):223-5. PubMed ID: 15678241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    Olson J; Huntington J
    J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.